BNTX logo

BioNTech SE (BNTX) Cash from financing

annual CFF:

-$49.65M+$792.11M(+94.10%)
December 31, 2024

Summary

  • As of today (August 18, 2025), BNTX annual cash flow from financing activities is -$49.65 million, with the most recent change of +$792.11 million (+94.10%) on December 31, 2024.
  • During the last 3 years, BNTX annual CFF has fallen by -$160.99 million (-144.59%).
  • BNTX annual CFF is now -104.87% below its all-time high of $1.02 billion, reached on December 31, 2020.

Performance

BNTX Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

quarterly CFF:

-$14.94M-$415.90K(-2.86%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX quarterly cash flow from financing activities is -$14.94 million, with the most recent change of -$415.90 thousand (-2.86%) on June 30, 2025.
  • Over the past year, BNTX quarterly CFF has increased by +$9.76 million (+39.50%).
  • BNTX quarterly CFF is now -102.11% below its all-time high of $707.34 million, reached on September 30, 2020.

Performance

BNTX quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFF:

-$46.22M+$9.76M(+17.43%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX TTM cash flow from financing activities is -$46.22 million, with the most recent change of +$9.76 million (+17.43%) on June 30, 2025.
  • Over the past year, BNTX TTM CFF has increased by +$330.40 million (+87.73%).
  • BNTX TTM CFF is now -104.44% below its all-time high of $1.04 billion, reached on June 30, 2021.

Performance

BNTX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BNTX Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+94.1%+39.5%+87.7%
3 y3 years-144.6%+98.3%+94.5%
5 y5 years-111.6%-109.3%-107.9%

BNTX Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-144.6%+96.7%-371.5%+98.3%-2.7%+97.5%
5 y5-year-104.9%+96.7%-102.1%+98.3%-104.4%+97.5%
alltimeall time-104.9%+96.7%-102.1%+98.3%-104.4%+97.5%

BNTX Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$14.94M(+2.9%)
-$46.22M(-17.4%)
Mar 2025
-
-$14.52M(+79.5%)
-$55.97M(+12.1%)
Dec 2024
-$49.65M(-94.1%)
-$8.09M(-6.6%)
-$49.92M(+10.9%)
Sep 2024
-
-$8.66M(-64.9%)
-$44.99M(-88.1%)
Jun 2024
-
-$24.70M(+191.7%)
-$376.62M(-29.2%)
Mar 2024
-
-$8.47M(+167.2%)
-$532.11M(-36.4%)
Dec 2023
-$841.76M(-43.6%)
-$3.17M(-99.1%)
-$836.19M(-4.0%)
Sep 2023
-
-$340.29M(+88.8%)
-$871.17M(-27.7%)
Jun 2023
-
-$180.19M(-42.3%)
-$1.21B(-36.0%)
Mar 2023
-
-$312.55M(+719.5%)
-$1.88B(+27.2%)
Dec 2022
-$1.49B(-1439.7%)
-$38.14M(-94.3%)
-$1.48B(-1.4%)
Sep 2022
-
-$674.14M(-21.4%)
-$1.50B(+79.8%)
Jun 2022
-
-$858.12M(-1052.6%)
-$835.29M(-503.6%)
Mar 2022
-
$90.08M(-250.5%)
$206.96M(+85.7%)
DateAnnualQuarterlyTTM
Dec 2021
$111.34M(-89.1%)
-$59.86M(+710.5%)
$111.46M(-65.8%)
Sep 2021
-
-$7.39M(-104.0%)
$325.84M(-68.7%)
Jun 2021
-
$184.13M(-3497.1%)
$1.04B(+2.3%)
Mar 2021
-
-$5.42M(-103.5%)
$1.02B(-0.7%)
Dec 2020
$1.02B(+137.8%)
$154.52M(-78.2%)
$1.02B(+0.7%)
Sep 2020
-
$707.34M(+341.1%)
$1.02B(+73.5%)
Jun 2020
-
$160.35M(+7141.1%)
$586.14M(+36.2%)
Mar 2020
-
$2.21M(-98.5%)
$430.23M(+0.3%)
Dec 2019
$429.00M(-0.4%)
$146.98M(-46.9%)
$429.10M(+52.1%)
Sep 2019
-
$276.59M(+6134.4%)
$282.12M(+5005.3%)
Jun 2019
-
$4.44M(+307.3%)
$5.53M(+407.3%)
Mar 2019
-
$1.09M
$1.09M
Dec 2018
$430.82M(<-9900.0%)
-
-
Dec 2017
-$1.85M
-
-

FAQ

  • What is BioNTech SE annual cash flow from financing activities?
  • What is the all time high annual CFF for BioNTech SE?
  • What is BioNTech SE annual CFF year-on-year change?
  • What is BioNTech SE quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for BioNTech SE?
  • What is BioNTech SE quarterly CFF year-on-year change?
  • What is BioNTech SE TTM cash flow from financing activities?
  • What is the all time high TTM CFF for BioNTech SE?
  • What is BioNTech SE TTM CFF year-on-year change?

What is BioNTech SE annual cash flow from financing activities?

The current annual CFF of BNTX is -$49.65M

What is the all time high annual CFF for BioNTech SE?

BioNTech SE all-time high annual cash flow from financing activities is $1.02B

What is BioNTech SE annual CFF year-on-year change?

Over the past year, BNTX annual cash flow from financing activities has changed by +$792.11M (+94.10%)

What is BioNTech SE quarterly cash flow from financing activities?

The current quarterly CFF of BNTX is -$14.94M

What is the all time high quarterly CFF for BioNTech SE?

BioNTech SE all-time high quarterly cash flow from financing activities is $707.34M

What is BioNTech SE quarterly CFF year-on-year change?

Over the past year, BNTX quarterly cash flow from financing activities has changed by +$9.76M (+39.50%)

What is BioNTech SE TTM cash flow from financing activities?

The current TTM CFF of BNTX is -$46.22M

What is the all time high TTM CFF for BioNTech SE?

BioNTech SE all-time high TTM cash flow from financing activities is $1.04B

What is BioNTech SE TTM CFF year-on-year change?

Over the past year, BNTX TTM cash flow from financing activities has changed by +$330.40M (+87.73%)
On this page